We also found that 17f, when associated with IM or Ara-C, inhibits expression of STAT5B but not STAT5A in resistant CML and AML cells via translational or post-translational mechanisms. The gene discussed is STAT5B; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.